Aptarion Biotech AG
- Address
- Max-Dohrn-Strasse 8-10, Charlottenburg
Sponsor Overview
Specializations
Respiratory Infection and Critical Care
Aptarion Biotech AG focuses on severe community-acquired pneumonia, with clinical interest centered on patients requiring intensive care or comparable hospital support. Its research activity is directed toward treatment settings where respiratory infection is accompanied by marked clinical severity and risk of complications.
- Severe community-acquired pneumonia
- Intensive care unit management
- Acute respiratory infection
The sponsor’s clinical research footprint includes active work across multiple countries and collaborating sites, reflecting an interest in complex hospital-based management of serious pulmonary infection.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of AON-D21 Efficacy and Safety in Severe Community-Acquired Pneumonia: A Randomized, Double-Blind, Placebo-Controlled Trial |  Belgium France Germany Spain | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 23 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
23 centres- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- 20 Boulevard General Maurice Guillaudot, 56000 Vannes
- Address
- Boulevard Stephane Moreau, 85925 La Roche sur Yon
- Address
- 2 Avenue Martin Luther King, 87000 Limoges
- Address
- 270 avenue Marc Jacquet, 77000 Melun
- Address
- 2 Boulevard Tonnelle, 37044 Tours
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Aptarion Biotech AG.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.